Combination comprising HDAC inhibitor, LAG-3 inhibitor and a PD-1 inhibitor or PD-L1 inhibitor for cancer treatment

• 收藏
• 分享

专利权人:

4SC AG

发明人:

BARTZ, René,HERMANN, Frank

申请号：

AU2019254578

公开号：

AU2019254578A1

申请日:

2019.04.17

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The invention relates to medical uses of an HDAC inhibitor of the below general formula I, wherein R1 to R7 are as described herein, or a salt or solvate thereof in combination with LAG-3 inhibitor and a PD-1 inhibitor or PD-L1 inhibitor for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/